News
We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...
In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...
Global drugmakers' stocks dropped across the board after U.S. President Donald Trump reiterated plans for a "major" tariff on pharmaceutical imports, threatening an interwoven global supply chain ...
Votre e-mail, avec votre consentement, est utilisé par la société Additi Multimedia pour recevoir les newsletters sélectionnées. En savoir plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results